Uncategorized

ADVISORY PANEL VOTED 6-1 TO RECOMMEND THAT US FDA DECLINE TO APPROVE DUROLANE INJECTION

WASHINGTON, Aug 19 (Reuters) – A U.S. Food and Drug Administration advisory panel on Wednesday:

REJECTED DUROLANE KNEE PAIN INJECTION FROM Q-MED AND SMITH & NEPHEW

VOTED 6-1 TO RECOMMEND THAT US FDA DECLINE TO APPROVE DUROLANE INJECTION (Company news desk in Washington; +1 202 898 8400, washington.newsroom@reuters.com)

COPYRIGHT

Josh Sandberg

Josh Sandberg is the President of Ortho Spine Partners and Partner for The De Angelis Group. He also serves as Co-Founder and Editor of OrthoSpineNews.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close
Themed By teapots